Which chemotherapy drugs have the highest cardiotoxicity risk in pediatric cancer?
A recent study published in JAMA Oncology analyzed data generated from over 28,000 childhood cancer survivors and compared the lifetime...
Apr 16, 2019
Drug Shortages Threaten Childhood Cancer Treatment
Despite the vital need for these drugs, they are often in short supply. A new paper published in JAMA Pediatrics discusses these drug...
Apr 2, 2019
Mitoxantrone for childhood cancer more cardiotoxic than thought
In pediatric cancer patients, mitoxantrone appears to be at least ten times as cardiotoxic as doxorubicin therapy, while daunorubicin...
Feb 14, 2019
Promising drug for pediatric leukemia in developing stages
Scientists from Northwestern Medicine have found that if they could stabilize the MLL protein -- the one responsible for the spread of...
Dec 28, 2018
Novartis receives Health Canada approval of its CAR-T cell therapy, Kymriah™
Novartis is pleased to announce that following a Priority Review, Health Canada has approved Kymriah™ (tisagenlecleucel/ CTL019) the...
Sep 6, 2018
Pre-clinical data suggests Noxopharm’s anti-cancer drug can boost radiation effect on paediatric bra
Pre-clinical data has confirmed Noxopharm’s (ASX: NOX) experimental idronoxil anti-cancer drug can boost the killing effect of radiation...
Jul 6, 2018
Larotrectinib shows promise in paediatric patients with TRK gene mutations
A new cancer drug has proven safe and effective for pediatric patients with a rare tumour gene mutation. The study tested the safety and...
Apr 9, 2018
Potential Cognitive Effects of Targeted Drugs in Children may be Reversible with Therapy
Young mice that received molecularly targeted therapies used to treat brain cancer in human patients sustained cognitive and behavioural...
Mar 22, 2018
Senate passes bill to improve cancer drugs for children
The Senate on Thursday overwhelmingly passed legislation requiring the pharmaceutical industry to expend more resources on treatment for...
Aug 4, 2017
Doxorubicin, cyclophosphamide in childhood increases risk for second malignancies
Patients who received doxorubicin for childhood cancers faced an increased risk for breast cancer and solid tumors later in life,...
Jun 16, 2017